)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Jointown Pharmaceutical Group
Jointown Pharmaceutical Group (600998) investor relations material
Jointown Pharmaceutical Group Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary23 Oct, 2026
Executive summary
Q3 revenue rose 10.32% YoY to RMB 42.17bn; adjusted attributable net profit rose 9.75% YoY and 29.45% QoQ to RMB 568.6m.
9M revenue grew 8.48% to RMB 129.45bn and adjusted attributable net profit increased 5.52% to RMB 1.551bn, driven by growth across core businesses.
9M reported attributable net profit declined 14.85%, primarily reflecting lower non-recurring gains than in the prior-year period.
Financial highlights
Q3 revenue was RMB 42.166bn, up 10.32% YoY; attributable net profit was RMB 481.6m, down 9.11%, while adjusted attributable net profit was RMB 568.6m, up 9.75%.
9M revenue reached RMB 129.445bn, up 8.48%; total profit was RMB 2.297bn, down 14.87%, and attributable net profit was RMB 1.682bn, down 14.85%.
9M operating cash flow was negative RMB 2.019bn, improving 12.83% YoY; Q3 operating cash flow was positive RMB 761m.
Outlook and guidance
Full-year operating cash flow is expected to be positive and aligned with operating performance; increased receivables collection is planned for Q4.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Jointown Pharmaceutical Group
- Revenue up 7.61% and core profit up 3.22%, with digital and retail segments driving growth.600998
Q2 2026 - Revenue up 6.31% to ¥161.39B, adjusted net profit up 9.13%, AAA credit rating achieved.600998Q4 2025
- Adjusted net profit rose 7.12% on 6.58% revenue growth, but reported profit fell due to lower one-time gains.600998Q1 2026
- Q3 2025 delivered solid profit growth, digital expansion, and a successful REITs listing.600998Q3 2025
- Net profit rose 19.70% on 5.10% revenue growth, with strong digital and retail expansion.600998Q2 2025
- Q3 saw resumed growth in revenue and profit, with digital and REITs strategies advancing.600998Q3 2024
- Adjusted net profit up 9.5% year-over-year; Q2 profit and cash flow improved sequentially.600998Q2 2024
- Net profit grew 15.33% to ¥2.51B, with strong cash flow and major REITs issuance.600998Q4 2024
- Net profit surged 80.38% in Q1 2025, driven by a major REITs transaction gain.600998Q1 2025
Next Jointown Pharmaceutical Group earnings date
Q4 202627 Apr, 2027
Jointown Pharmaceutical Group
Next Jointown Pharmaceutical Group earnings date
Q4 202627 Apr, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)